The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats
Abstract
Facilitation of memory extinction by manipulation of the endocannabinoid (eCB) system has been recently studied in several paradigms. Our previous results pointed to facilitation of contextual fear memory extinction by a low dose of a cannabinoid agonist, with a suggestion of short-term effects. The aim of the present study was to further investigate the effects of cannabinoid drugs in the short- and long-term extinction of conditioned fear using an extended extinction protocol. Male Wistar rats were placed in a conditioning chamber and after 3min received a footshock (1.5mA, 1s). On the next day, they received i.p. drug treatment (WIN55212-2 0.25mg/kg, AM404 10mg/kg, SR141716A 1mg/kg) and were re-exposed to the conditioning chamber for 30min (extinction training). No-Extinction groups received the same drug treatment, but were exposed for 3min to the conditioning chamber. A drug-free test of contextual memory (3min) was performed 7 days later. The cannabinoid agonist WI55212-2 and the inhibitor of eCB metabolism/uptake AM404 facilitated short-term extinction. In addition, long-term effects induced by treatments with WIN55212 and AM404 were completely divergent to those of SR141716A treatment. The present results confirm and extend previous findings showing that the eCB system modulates short-term fear memory extinction with long-lasting consequences.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Augmenting levels of anandamide in the amygdala modulates short-term fear extinction9”
From Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study (2013) · cites this paper as [9]
In the citing paper
“Activating CB1R via systemic or intra-hippocampal or -mPFC administration of either the CB1R agonist, WIN55212-2, the ECB reuptake blocker, AM404, or AEA itself has been shown to facilitate rodent fear extinction, in most cases without affecting conditioned fear [89,95–98] (but see [90]).”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [95]
Citations
Cites
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Memory Reconsolidation and Extinction Have Distinct Temporal and Biochemical Signatures
Suzuki, A., Josselyn, S. A., Frankland, P. W., Masushige, S., Silva, A. J., & Kida, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5491-03.2004 · Cited by 1,127
Crouching as an index of fear.
Blanchard, R. J., & Blanchard, D. C. (1969) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0026779 · Cited by 1,077
Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear
Chhatwal, J. P., Davis, M., Maguschak, K. A., & Ressler, K. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300655 · Cited by 376
Evaluation of CB1 Receptor Knockout Mice in the Morris Water Maze
Varvel, S. A., & Lichtman, A. H. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.915 · Cited by 245
Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404
Bortolato, M., Campolongo, P., Mangieri, R. A., Scattoni, M. L., Frau, R., Trezza, V., Rana, G. L., Russo, R., Calignano, A., Gessa, G. L., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301061 · Cited by 236
Cannabinoid CB1 Receptor Mediates Fear Extinction via Habituation-Like Processes
Kamprath, K., Marsicano, G., Tang, J., Monory, K., Bisogno, T., Marzo, V. D., Lutz, B., & Wotjak, C. T. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0153-06.2006 · Cited by 217
Pamplona, F. A., Prediger, R. D. S., Pandolfo, P., & Takahashi, R. N. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0514-0 · Cited by 211
Self-citationVarvel, S. A., Wise, L. E., Niyuhire, F., Cravatt, B. F., & Lichtman, A. H. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301224 · Cited by 179
Parker, L. A., Burton, P., Sorge, R. E., Yakiwchuk, C., & Mechoulam, R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1825-7 · Cited by 171
Cited by
Sorted by citations
Neurobiological Interactions Between Stress and the Endocannabinoid System
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 698
Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 505
Targeting Cortical Representations in the Treatment of Chronic Pain
Moseley, G. L., & Flor, H. (2012) · Neurorehabilitation and neural repair · doi:10.1177/1545968311433209 · Cited by 482
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“AM404 (eCB uptake inhibitor) ns + ns ip (Pamplona et al., 2008)”
BackgroundInfluentialNeumeister, A., Normandin, M. D., Pietrzak, R. H., Piomelli, D., Zheng, M. Q., Gujarro-Anton, A., Potenza, M. N., Bailey, C. R., Lin, S. F., Najafzadeh, S., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.61 · Cited by 361
Gunduz-Cinar, O., MacPherson, K. P., Cinar, R., Gamble-George, J., Sugden, K., Williams, B., Godlewski, G., Ramikie, T. S., Gorka, A. X., Alapafuja, S. O., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.72 · Cited by 307
Hill, M. N., Campolongo, P., Yehuda, R., & Patel, S. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.162 · Cited by 250
The endocannabinoid system in anxiety, fear memory and habituation
Ruehle, S., Rey, A. A., Remmers, F., & Lutz, B. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408958 · Cited by 236
Amygdala FAAH and anandamide: mediating protection and recovery from stress
Gunduz-Cinar, O., Hill, M. N., McEwen, B. S., & Holmes, A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.008 · Cited by 229
Effects of endocannabinoid system modulation on cognitive and emotional behavior
Zanettini, C. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00057 · Cited by 214
Cannabidiol enhances consolidation of explicit fear extinction in humans
Das, R., Kamboj, S. K., Ramadas, M., Yogan, K., Gupta, V., Redman, E., Curran, H. V., & Morgan, C. J. A. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2955-y · Cited by 200
Cannabinoids modulate hippocampal memory and plasticity
Abush, H., & Akirav, I. (2010) · Hippocampus · doi:10.1002/hipo.20711 · Cited by 186
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 188
Ganon-Elazar, E., & Akirav, I. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1223-09.2009 · Cited by 173
Cannabinoid facilitation of fear extinction memory recall in humans
Rabinak, C. A., Angstadt, M., Sripada, C. S., Abelson, J. L., Liberzon, I., Milad, M. R., & Phan, K. L. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.063 · Cited by 163
Can fear extinction be enhanced? A review of pharmacological and behavioral findings
Fitzgerald, P. J., Seemann, J. R., & Maren, S. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.12.007 · Cited by 167
PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program
Greer, G. R., Grob, C. S., & Halberstadt, A. L. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.873843 · Cited by 149
PTSD: from neurobiology to pharmacological treatments
Kelmendi, B., Adams, T., Yarnell, S. C., Southwick, S., Abdallah, C., & Krystal, J. (2016) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v7.31858 · Cited by 136
Rabinak, C. A., Angstadt, M., Lyons, M., Mori, S., Milad, M. R., Liberzon, I., & Phan, K. L. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.09.009 · Cited by 148
Riebe, C. J. N., & Wotjak, C. T. (2011) · Stress · doi:10.3109/10253890.2011.586753 · Cited by 149
The use of cognitive enhancers in animal models of fear extinction
Kaplan, G. B., & Moore, K. A. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.009 · Cited by 113
Pharmacological Enhancement of Memory and Executive Functioning in Laboratory Animals
Floresco, S., & Jentsch, J. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.158 · Cited by 120
Llorente‐Berzal, A., Terzian, A. L. B., Marzo, V. D., Micale, V., Viveros, M., & Wotjak, C. T. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3917-y · Cited by 112
The Neurobiological Bases of Memory Formation: From Physiological Conditions to Psychopathology
Bisaz, R., Travaglia, A., & Alberini, C. M. (2014) · Psychopathology · doi:10.1159/000363702 · Cited by 124
Cannabinoid Regulation of Fear and Anxiety: an Update
Papagianni, E. P., & Stevenson, C. W. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1026-z · Cited by 108
Akirav, I. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00034 · Cited by 102
Ganon-Elazar, E., & Akirav, I. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.01.014 · Cited by 98
Morena, M., Berardi, A., Colucci, P., Palmery, M., Trezza, V., Hill, M. N., & Campolongo, P. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.305 · Cited by 96
de Bitencourt, R. M., & Takahashi, R. N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00502 · Cited by 108
Self-citationEndocannabinoid-mediated synaptic plasticity and addiction-related behavior
Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92
Molecular Specificity of Multiple Hippocampal Processes Governing Fear Extinction
Radulović, J., & Tronson, N. C. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.1.1 · Cited by 83
Finn, D. P. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.05.011 · Cited by 91
Trezza, V., & Campolongo, P. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00100 · Cited by 87
Choi, K. H., Le, T., McGuire, J. L., Xing, G., Zhang, L., Li, H., Parker, C. C., Johnson, L. R., & Ursano, R. J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.021 · Cited by 84
Fear as a translational mechanism in the psychopathology of anorexia nervosa
Murray, S. B., Strober, M., Craske, M. G., Griffiths, S., Levinson, C. A., & Strigo, I. A. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.013 · Cited by 75
Fear relief—toward a new conceptual frame work and what endocannabinoids gotta do with it
Riebe, C. J. N., Pamplona, F. A., Kamprath, K., & Wotjak, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.057 · Cited by 84
Self-citationde Bitencourt, R. M., Pamplona, F. A., & Takahashi, R. N. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.039 · Cited by 80
Self-citationBerardi, A., Schelling, G., & Campolongo, P. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.024 · Cited by 77
Endocannabinoids: Effectors of glucocorticoid signaling
Balsevich, G., Petrie, G. N., & Hill, M. N. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.07.005 · Cited by 82
Sex‐dependent effects of endocannabinoid modulation of conditioned fear extinction in rats
Morena, M., Nastase, A. S., Santori, A., Cravatt, B. F., Shansky, R. M., & Hill, M. N. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15341 · Cited by 72
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1
Heitland, I., Klumpers, F., Oosting, R. S., Evers, D. J. J., Kenemans, J. L., & Baas, J. M. P. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.90 · Cited by 72
Bukalo, O., Pinard, C. R., & Holmes, A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12779 · Cited by 73
Campolongo, P., Morena, M., Scaccianoce, S., Trezza, V., Chiarotti, F., Schelling, G., Cuomo, V., & Roozendaal, B. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.26 · Cited by 70
Developmental regulation of fear learning and anxiety behavior by endocannabinoids
Lee, T. T.-Y., Hill, M. N., & Lee, F. S. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12253 · Cited by 71
2-arachidonoylglycerol signaling impairs short-term fear extinction
Hartley, N. D., Gunduz‐Cinar, O., Halladay, L. R., Bukalo, O., Holmes, A., & Patel, S. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.26 · Cited by 66
Wise, L. E., Long, K. A., Abdullah, R. A., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200130s · Cited by 66
Targeting the endocannabinoid system to treat anxiety-related disorders
Korem, N., Zer‐Aviv, T. M., Ganon-Elazar, E., Abush, H., & Akirav, I. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0058 · Cited by 69
Maćkowiak, M., Chocyk, A., Dudys, D., & Wędzony, K. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.037 · Cited by 65
Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSD
Ney, L. J., Akhurst, J., Bruno, R., Laing, P. A. F., Matthews, A. J., & Felmingham, K. L. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110118 · Cited by 62
Morena, M., Aukema, R. J., Leitl, K. D., Rashid, A. J., Vecchiarelli, H. A., Josselyn, S. A., & Hill, M. N. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2251-18.2018 · Cited by 68
A cortico-amygdala neural substrate for endocannabinoid modulation of fear extinction
Gunduz‐Cinar, O., Castillo, L. I., Xia, M. Y., Leer, E. V., Brockway, E. T., Pollack, G. A., Yasmin, F., Bukalo, O., Limoges, A., Oreizi-Esfahani, S., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.06.023 · Cited by 64
Cognitive enhancers for facilitating drug cue extinction: Insights from animal models
Dhonnchadha, B. Á. N., & Kantak, K. M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.018 · Cited by 57
Pharmacological enhancement of fear reduction: preclinical models
Graham, B. M., Langton, J. M., & Richardson, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01175.x · Cited by 57
The Endocannabinoid System and Anxiety
Lisboa, S. F. D. S., Gomes, F. V., Terzian, A. L. B., de Aguiar, D. C., Moreira, F. A., Resstel, L. B. M., & Guimarães, F. S. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.09.006 · Cited by 56
Lisboa, S. F., Vila-Verde, C., Rosa, J., Uliana, D. L., Stern, C. A. J., Bertoglio, L. J., Resstel, L. B., & Guimaraes, F. S. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5127-x · Cited by 54
Effects of endocannabinoid and endovanilloid systems on aversive memory extinction
Laricchiuta, D., Centonze, D., & Petrosini, L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.010 · Cited by 54
Stern, C. A. J., de Carvalho, C. R., Bertoglio, L. J., & Takahashi, R. N. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.07.018 · Cited by 53
Self-citationBurstein, O., Shoshan, N., Doron, R., & Akirav, I. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.01.026 · Cited by 54
Crombie, K. M., Sartin‐Tarm, A., Sellnow, K. A., Ahrenholtz, R., Lee, S., Matalamaki, M., Adams, T. G., & Cisler, J. M. (2021) · Behaviour Research and Therapy · doi:10.1016/j.brat.2021.103867 · Cited by 48
Rabinak, C. A., & Phan, K. L. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990437 · Cited by 49
Sink, K. S., Segovia, K. N., Collins, L. E., Markus, E. J., Vemuri, K. V., Makriyannis, A., & Salamone, J. D. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.03.011 · Cited by 44
Segev, A., & Akirav, I. (2011) · Learning & Memory · doi:10.1101/lm.2110511 · Cited by 41
Hammoud, M. Z., Peters, C., Hatfield, J. R. B., Gorka, S. M., Phan, K. L., Milad, M. R., & Rabinak, C. A. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0416-6 · Cited by 40
The endocannabinoid system in the amygdala and modulation of fear
Gunduz‐Cinar, O. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110116 · Cited by 40
Papini, S., Sullivan, G. M., Hien, D. A., Shvil, E., & Neria, Y. (2014) · Biological Psychology · doi:10.1016/j.biopsycho.2014.10.010 · Cited by 37
Xing, G., Carlton, J. R., Jiang, X., Wen, J., Jia, M., & Li, H. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00161 · Cited by 39
The role of the cannabinoid system in fear memory and extinction in male and female mice
Mizuno, I., Matsuda, S., Tohyama, S., & Mizutani, A. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105688 · Cited by 37
Ford, G. K., Kieran, S., Dolan, K., Harhen, B., & Finn, D. P. (2011) · Pain · doi:10.1016/j.pain.2011.07.014 · Cited by 32
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats
de Carvalho, C. R., Pamplona, F. A., Cruz, J. S., & Takahashi, R. N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3331-2 · Cited by 31
Self-citationTargeting the Endocannabinoid System in Psychiatric Illness
Katzman, M. A., Furtado, M., & Anand, L. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000581 · Cited by 30
Goonawardena, A. V., Sesay, J., Sexton, C. A., Riedel, G., & Hampson, R. E. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.003 · Cited by 28
Fattore, L., Piva, A., Zanda, M. T., Fumagalli, G. F., & Chiamulera, C. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4793-4 · Cited by 26
Endocannabinoids as Therapeutic Targets
Prospero-Garcia, O. E., Ruiz‐Contreras, A. E., Ortega-Gómez, A., Herrera-Solís, A., & Méndez‐Díaz, M. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.09.005 · Cited by 26
Powers, M. S., Barrenha, G. D., Mlinac, N. S., Barker, E. L., & Chester, J. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1997-2 · Cited by 24
Zabik, N. L., Rabinak, C. A., Peters, C. A., & Iadipaolo, A. S. (2023) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2023.107758 · Cited by 22
Corticosteroid–endocannabinoid loop supports decrease of fear-conditioned response in rats
de Bitencourt, R. M., Pamplona, F. A., & Takahashi, R. N. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.010 · Cited by 23
Self-citationBennett, M. R., Arnold, J. C., Hatton, S. N., & Lagopoulos, J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.11.029 · Cited by 22
Rattray, I., Scullion, G. A., Soulby, A., Kendall, D. A., & Pardon, M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.037 · Cited by 19
Marchetta, E., Mancini, G. F., Morena, M., & Campolongo, P. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221207162750 · Cited by 17
Phosphorylation of PSD-95 at serine 73 in dCA1 is required for extinction of contextual fear
Ziółkowska, M., Borczyk, M., Cały, A., Nalberczak‐Skóra, M., Śliwińska, M. A., Robacha, M., Łukasiewicz, K., Skonieczna, E., Tomaszewski, K. F., Tomaszewski, K. F., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002106 · Cited by 18
Kondev, V., Winters, N. D., & Patel, S. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.007 · Cited by 21
Interplay between serotonin and cannabinoid function in the amygdala in fear conditioning
Nasehi, M., Davoudi, K., Ebrahimi-Ghiri, M., & Zarrindast, M. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.034 · Cited by 17
Developmental differences in the effects of CB1/2R agonist WIN55212-2 on extinction of learned fear
Bisby, M. A., Richardson, R., & Baker, K. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109834 · Cited by 15
In it together? The case for endocannabinoid–noradrenergic interactions in fear extinction
Warren, W. G., Papagianni, E. P., Stevenson, C. W., & Stubbendorff, C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15200 · Cited by 18
Pharmacological effects of cannabinoids on the reference and working memory functions in mice
Avdesh, A., Hoe, Y., Martins, R. N., & Martin-Iverson, M. T. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2834-6 · Cited by 16
Mizuno, I., & Matsuda, S. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00246-y · Cited by 17
Endocannabinoid interactions in the regulation of acquisition of contextual conditioned fear
Balogh, Z., Szente, L., Bíró, L., Varga, Z. K., Haller, J., & Aliczki, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.11.007 · Cited by 16
Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder
Alexander, C., & Vasefi, M. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2021.08.001 · Cited by 12
Zabik, N. L., Iadipaolo, A. S., Peters, C. A., Baglot, S. L., Hill, M. N., & Rabinak, C. A. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06702-w · Cited by 11
The endocannabinoid system and emotional processing: pathophysiology and therapeutic potential
Finn, D. P., Viveros, M., & Marco, E. M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111428526 · Cited by 10
Paredes-Ruiz, K. J., Chavira-Ramos, K., Orozco‐Morales, M., Karasu, Ç., Tinkov, A. A., Aschner, M., Santamarı́a, A., & Colín-González, A. L. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00424-z · Cited by 10
Scienza-Martin, K., Lotz, F. N., Zanona, Q. K., Santana, F., Crestani, A. P., Boos, F. Z., Calcagnotto, M. E., & Quillfeldt, J. A. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.04.009 · Cited by 11
Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation
Loomba, N., & Patel, S. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00961-y · Cited by 11
Bisby, M. A., Baker, K., & Richardson, R. (2018) · Learning & Memory · doi:10.1101/lm.047209.117 · Cited by 8
Cannabis and Complex Posttraumatic Stress Disorder
Dagan, Y., & Yager, J. (2020) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001172 · Cited by 7
Velikova, M., Doncheva, D., & Tashev, R. E. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2020-025 · Cited by 7
Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder
Ney, L. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125527 · Cited by 6
Lightfoot, S. H. M., Nastase, A. S., Cesar, G. C. L., Hume, C., Gom, R. C., Teskey, G. C., & Hill, M. N. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06748-4 · Cited by 5
Aliczki, M., & Haller, J. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_4 · Cited by 5
de Carvalho, C. R., Stern, C. A. J., Bertoglio, L. J., & Takahashi, R. N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00075-4 · Cited by 4
Self-citation
Metadata
- Authors
- Pamplona, F. A., Bitencourt, R. M., & Takahashi, R. N.
- Affiliations
- Universidade Federal de Santa Catarina (BR)
- Corresponding author
- Takahashi, Reinaldo N.
- Venue
- Neurobiology of Learning and Memory
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 90
- Issue
- 1
- Pages
- 290-293
- ISSN
- 1074-7427 (ISSN-L)
- OpenAlex
- W2001442529
- Cited by
- 123
- References
- 18
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 7 · 2018: 7 · 2017: 6 · 2016: 10 · 2015: 7 · 2014: 9 · 2013: 12 · 2012: 12
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurobiology of Learning and Memory (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sanofi
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Universidade Federal de Santa Catarina
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory Processes and Influences
- Keywords
- cannabinoids, endocannabinoid system, fear extinction, contextual fear memory, WIN 55,212-2, AM404, SR141716A, cannabinoid receptor agonists, cannabinoid receptor antagonists, long-term memory effects
- MeSH terms
- Rimonabant, Animals, Arachidonic Acids, Calcium Channel Blockers, Cannabinoids, Conditioning, Psychological, Extinction, Psychological, Fear, Male, Memory, Morpholines, Naphthalenes, Piperidines, Pyrazoles, Time Factors, Rats, Wistar, Freezing Reaction, Cataleptic, Benzoxazines, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review